Viral tests determine whether a person has an active COVID-19 infection. Our tests are among the highest performing options on the market for detecting active COVID-19 infections. Results available within 12, 24, or 48 hours of sample arrival at the laboratory.
Assays: Hologic Aptima, Roche, and PANDAA
*This test is only for use under the Food and Drug Administration's Emergency Use Authorization. This laboratory-developed test has been validated in accordance with CLIA and FDA's Guidance Document (Policy for Diagnostic Tests for Coronavirus Disease-2019 during the Public Health Emergency Immediately in Effect Guidance for Clinical Laboratories, Commercial Manufacturers, and Food and Drug Administration Staff Document). This test service has not been FDA cleared or approved.
Remove swab from the sterile pouch without touching the swab tip
Insert at least 1 cm (1/2 inch) and rotate in place for 10-15 seconds
Insert sample into the transport tube and snap the swab at the breakpoint
Securely tighten the cap on the transport tube and prepare
Your test results will confirm whether or not you are actively infected with COVID-19.
If your results are positive, limit your exposure to other people and monitor your symptoms. As the CDC instructs, please alert healthcare providers of your test results before receiving medical care. However, do not delay seeking care if you are experiencing a medical emergency.
If your results are negative, the virus was not detected in the sample you provided. However, tests may not detect the virus in early stage infections or poor quality nasal swab samples. If you were exposed to COVID-19 but received negative test results, follow up with a healthcare provider for further evaluation.
You will have the opportunity to speak with a licensed physician to discuss your test results.
It is possible for your test results to be inconclusive. This can happen for a variety of reasons. A licensed physician will contact you for further evaluation.
Senneca Dx partners only with CLIA-certified 1 laboratories that have validated reverse transcriptase polymerase chain reaction (RT-PCR) assays that detect the virus at low levels.* These assays include the PANDAA (Pan-Degenerate Amplification and Adaptation), Hologic Aptima, Roche Cobas, and EuroImmune EURORealTime assays. These tests identify the genetic material of SARS-CoV-2, the virus that causes COVID-19. The lowest level where the assay can reliably detect the virus is called the limit of detection (LoD). Senneca DX laboratory partners offer best-in-class assays that demonstrate a limit of detection (LoD) of ~100 copies of viral RNA per milliliter of transport media.2
*This test is only for use under the Food and Drug Administration's Emergency Use Authorization. This laboratory-developed test has been validated in accordance with CLIA and FDA's Guidance Document (Policy for Diagnostic Tests for Coronavirus Disease-2019 during the Public Health Emergency Immediately in Effect Guidance for Clinical Laboratories, Commercial Manufacturers, and Food and Drug Administration Staff Document). This test service has not been FDA cleared or approved.
More Information: Patients | Healthcare Providers